Activity Description & Educational Objectives
In this activity, a panel of experts on Parkinson’s disease management discusses some of the clinical challenges associated with the management of this disease. Topics covered include considerations for the treatment selection for the management of motor symptoms in patients with early disease, potential adjunctive strategies for worsening motor symptoms, and motor complications in patients with advancing disease.
Upon completion of this activity, participants should be better able to:
- Apply key efficacy, safety, and tolerability data to available therapies when selecting a course of treatment for the management of motor symptoms in patients with early Parkinson’s disease (PD)
- Employ treatment algorithms to select appropriate adjunctive therapeutic strategies for the management of motor symptoms and complications in individual patients with PD
This activity has been designed to meet the educational needs of neurologists and other clinicians involved in the care of patients with Parkinson’s disease.
Requirements for Successful Completion
In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.
Release and Expiration Dates: December 27, 2012 - December 26, 2013
Time to Complete: 30 minutes
Faculty & Disclosure / Conflict of Interest Policy
In accordance with ACCME requirements, the University of Florida College of Medicine has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.
Course Director and Moderator
Michael S. Okun, MD
Professor of Neurology
Administrative Director and Co-Director, Center for Movement Disorders and Neurorestoration
Departments of Neurology, Neurosurgery, Psychiatry, and History
University of Florida College of Medicine
Michael S. Okun, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for National Parkinson Foundation.
Grant/Research Support from National Institutes of Health; National Parkinson Foundation; The Michael J. Fox Foundation for Parkinson's Research; and The Parkinson Alliance.
Other Financial or Material Support from Cambridge University Press; Demos Medical Publishing; Humana Press; and Manson in the form of royalties.
Joseph Jankovic, MD
Professor of Neurology
Distinguished Chair in Movement Disorders
Director, Parkinson’s Disease Center and Movement Disorders Clinic
Department of Neurology
Baylor College of Medicine
Joseph Jankovic, MD, has a financial interest/relationship or affiliation in the form of:
Grant/Research Support from Allergan, Inc; Allon Therapeutics; Biotie Therapies, Inc; Ceregene, Inc; CHDI Foundation; Chelsea Therapeutics; Diana Helis Henry Medical Research Foundation; EMD Serono; GE Healthcare; Huntington’s Disease Society of America; Huntington Study Group; Impax Pharmaceuticals; Ipsen Limited; Lundbeck Inc; Michael J Fox Foundation for Parkinson Research; Medtronic; Merz Pharmaceuticals; National Institutes of Health; National Parkinson Foundation; Neurogen Corp. (Ligand Pharmaceuticals, Inc.); Parkinson Study Group; St. Jude Medical, Inc.; Teva Pharmaceutical Industries Ltd.; and University of Rochester.
Honoraria from Allergan, Inc; Auspex Pharmaceuticals; Ipsen Limited; Lundbeck Inc; Merz Pharmaceuticals; Michael J. Fox Foundation for Parkinson Research; and Teva Pharmaceutical Industries Ltd.
Other Financial or Material Support from Cambridge University Press; Elsevier; Hodder Arnold Publishing; Lippincott Williams & Wilkins; and Wiley-Blackwell in the form of royalties. During the past two years Dr. Jankovic has served on the following editorial boards without financial compensation: Associate editor of The Botulinum Journal; Expert Review of Neurotherapeutics; MedLink Neurology; Neurology in Clinical Practice; Neurotherapeutics; The Journal of Parkinson’s Disease; Tremor and Other Hyperkinetic Movements; Therapeutic Advances in Neurological Disorders; and UpToDate, Inc.
Ramon L. Rodriguez, MD
Director of Clinics and Clinical Trials, Center for Movement Disorders and Neurorestoration
Director, Tyler’s Hope Center for Dystonia Care
Clinical Associate Professor, Neurology
University of Florida College of Medicine
Ramon L. Rodriguez, MD, has a financial interest/relationship or affiliation in the form of:
Grant/Research Support from Abbott Laboratories; Allergan, Inc.; Biotie Therapies; EMD Serono, Inc.; Huntington Study Group; Ipsen; Merz Pharmaceuticals, LLC; National Institutes of Health; National Institute of Neurological Disorders and Stroke; National Parkinson Foundation; NeuroNova; and Teva Pharmaceuticals USA. Dr. Rodriguez has no owner interest in any pharmaceutical company.
Honoraria from Corporate Meeting Solutions, LLC.; Lundbeck, Inc.; Merz Pharmaceuticals, LLC; PRIME Education, Inc.; PVI, PeerView Institute for Medical Education; and Teva Pharmaceuticals USA.
Kalina Sanders, MD
Assistant Professor of Neurology
University of Florida College of Medicine – Jacksonville
Kalina Sanders, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for EMD Serono, Inc.
Speakers Bureau participant with EMD Serono, Inc./Pfizer, Inc.; Biogen Idec; Teva Pharmaceuticals, Ltd.; and Novartis Pharmaceuticals Corporation.
Other Financial or Material Support from All financial relationships listed above have ended as of June 2012.
Kirk A. Tacka, PhD
PVI, PeerView Institute for Medical Education
Kirk A. Tacka, PhD, currently has no financial interests/relationships or affiliations in relation to this activity.
Sponsorship, Credit & Support
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Florida College of Medicine and PVI, PeerView Institute for Medical Education. The University of Florida College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Florida College of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This CME activity is jointly sponsored by the University of Florida College of Medicine and PVI, PeerView Institute for Medical Education.
This activity is supported by educational grants from
Disclosure of Unlabeled Use
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.
No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.
Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.